Drug Remdesivir by Gilead in Clinical Trial Looks Extremely Effective Helping Almost All Severe Wuhan Patients Recover


One of the hospitals in Chicago has just completed a clinical trial of remdesiver, a new drug from Gilead laboratories, the trial involving 125 wuhan virus patients, 113 of whom showing severe symptoms, of all those hospitalized only 2 perished, and almost all the other other severe cases remedied within a week, extremely promising indeed, another drug having been recommended by doctor Trump.